Effect of remifentanil on pre-osteoclast cell differentiation in vitro
The structure and function of bone tissue is maintained through a constant remodeling process, which is maintained by the balance between osteoblasts and osteoclasts. The failure of bone remodeling can lead to pathological conditions of bone structure and function. Remifentanil is currently used as...
Saved in:
Published in | Journal of dental anesthesia and pain medicine: JDAPM Vol. 18; no. 1; pp. 9 - 17 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Dental Society of Anesthsiology
01.02.2018
대한치과마취과학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2383-9309 2383-9317 |
DOI | 10.17245/jdapm.2018.18.1.9 |
Cover
Abstract | The structure and function of bone tissue is maintained through a constant remodeling process, which is maintained by the balance between osteoblasts and osteoclasts. The failure of bone remodeling can lead to pathological conditions of bone structure and function. Remifentanil is currently used as a narcotic analgesic agent in general anesthesia and sedation. However, the effect of remifentanil on osteoclasts has not been studied. Therefore, we investigated the effect of remifentanil on pre-osteoclast (pre-OCs) differentiation and the mechanism of osteoclast differentiation in the absence of specific stimulus.
Pre-OCs were obtained by culturing bone marrow-derived macrophages (BMMs) in osteoclastogenic medium for 2 days and then treated with various concentration of remifentanil. The mRNA expression of NFATc1 and c-fos was examined by using real-time PCR. We also examined the effect of remifentanil on the osteoclast-specific genes TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. Finally, we examined the influence of remifentanil on the migration of pre-OCs by using the Boyden chamber assay.
Remifentanil increased pre-OC differentiation and osteoclast size, but did not affect the mRNA expression of NFATc1 and c-fos or significantly affect the expression of TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. However, remifentanil increased the migration of pre-OCs.
This study suggested that remifentanil promotes the differentiation of pre-OCs and induces maturation, such as increasing osteoclast size. In addition, the increase in osteoclast size was mediated by the enhancement of pre-OC migration and cell fusion. |
---|---|
AbstractList | The structure and function of bone tissue is maintained through a constant remodeling process, which is maintained by the balance between osteoblasts and osteoclasts. The failure of bone remodeling can lead to pathological conditions of bone structure and function. Remifentanil is currently used as a narcotic analgesic agent in general anesthesia and sedation. However, the effect of remifentanil on osteoclasts has not been studied. Therefore, we investigated the effect of remifentanil on pre-osteoclast (pre-OCs) differentiation and the mechanism of osteoclast differentiation in the absence of specific stimulus.
Pre-OCs were obtained by culturing bone marrow-derived macrophages (BMMs) in osteoclastogenic medium for 2 days and then treated with various concentration of remifentanil. The mRNA expression of NFATc1 and c-fos was examined by using real-time PCR. We also examined the effect of remifentanil on the osteoclast-specific genes TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. Finally, we examined the influence of remifentanil on the migration of pre-OCs by using the Boyden chamber assay.
Remifentanil increased pre-OC differentiation and osteoclast size, but did not affect the mRNA expression of NFATc1 and c-fos or significantly affect the expression of TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. However, remifentanil increased the migration of pre-OCs.
This study suggested that remifentanil promotes the differentiation of pre-OCs and induces maturation, such as increasing osteoclast size. In addition, the increase in osteoclast size was mediated by the enhancement of pre-OC migration and cell fusion. Background: The structure and function of bone tissue is maintained through a constant remodeling process, which is maintained by the balance between osteoblasts and osteoclasts. The failure of bone remodeling can lead to pathological conditions of bone structure and function. Remifentanil is currently used as a narcotic analgesic agent in general anesthesia and sedation. However, the effect of remifentanil on osteoclasts has not been studied. Therefore, we investigated the effect of remifentanil on pre-osteoclast (pre-OCs) differentiation and the mechanism of osteoclast differentiation in the absence of specific stimulus. Methods: Pre-OCs were obtained by culturing bone marrow-derived macrophages (BMMs) in osteoclastogenic medium for 2 days and then treated with various concentration of remifentanil. The mRNA expression of NFATc1 and c-fos was examined by using real-time PCR. We also examined the effect of remifentanil on the osteoclast-specific genes TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. Finally, we examined the influence of remifentanil on the migration of pre-OCs by using the Boyden chamber assay. Results: Remifentanil increased pre-OC differentiation and osteoclast size, but did not affect the mRNA expression of NFATc1 and c-fos or significantly affect the expression of TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. However, remifentanil increased the migration of pre-OCs. Conclusions: This study suggested that remifentanil promotes the differentiation of pre-OCs and induces maturation, such as increasing osteoclast size. In addition, the increase in osteoclast size was mediated by the enhancement of pre-OC migration and cell fusion. KCI Citation Count: 0 The structure and function of bone tissue is maintained through a constant remodeling process, which is maintained by the balance between osteoblasts and osteoclasts. The failure of bone remodeling can lead to pathological conditions of bone structure and function. Remifentanil is currently used as a narcotic analgesic agent in general anesthesia and sedation. However, the effect of remifentanil on osteoclasts has not been studied. Therefore, we investigated the effect of remifentanil on pre-osteoclast (pre-OCs) differentiation and the mechanism of osteoclast differentiation in the absence of specific stimulus.BACKGROUNDThe structure and function of bone tissue is maintained through a constant remodeling process, which is maintained by the balance between osteoblasts and osteoclasts. The failure of bone remodeling can lead to pathological conditions of bone structure and function. Remifentanil is currently used as a narcotic analgesic agent in general anesthesia and sedation. However, the effect of remifentanil on osteoclasts has not been studied. Therefore, we investigated the effect of remifentanil on pre-osteoclast (pre-OCs) differentiation and the mechanism of osteoclast differentiation in the absence of specific stimulus.Pre-OCs were obtained by culturing bone marrow-derived macrophages (BMMs) in osteoclastogenic medium for 2 days and then treated with various concentration of remifentanil. The mRNA expression of NFATc1 and c-fos was examined by using real-time PCR. We also examined the effect of remifentanil on the osteoclast-specific genes TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. Finally, we examined the influence of remifentanil on the migration of pre-OCs by using the Boyden chamber assay.METHODSPre-OCs were obtained by culturing bone marrow-derived macrophages (BMMs) in osteoclastogenic medium for 2 days and then treated with various concentration of remifentanil. The mRNA expression of NFATc1 and c-fos was examined by using real-time PCR. We also examined the effect of remifentanil on the osteoclast-specific genes TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. Finally, we examined the influence of remifentanil on the migration of pre-OCs by using the Boyden chamber assay.Remifentanil increased pre-OC differentiation and osteoclast size, but did not affect the mRNA expression of NFATc1 and c-fos or significantly affect the expression of TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. However, remifentanil increased the migration of pre-OCs.RESULTSRemifentanil increased pre-OC differentiation and osteoclast size, but did not affect the mRNA expression of NFATc1 and c-fos or significantly affect the expression of TRAP, cathepsin K, calcitonin receptor, and DC-STAMP. However, remifentanil increased the migration of pre-OCs.This study suggested that remifentanil promotes the differentiation of pre-OCs and induces maturation, such as increasing osteoclast size. In addition, the increase in osteoclast size was mediated by the enhancement of pre-OC migration and cell fusion.CONCLUSIONSThis study suggested that remifentanil promotes the differentiation of pre-OCs and induces maturation, such as increasing osteoclast size. In addition, the increase in osteoclast size was mediated by the enhancement of pre-OC migration and cell fusion. |
Author | Yoon, Ji-Uk Cho, Ah-Reum Choi, In-Seok Kim, Hyung-Joon Kim, Cheul-Hong Jeon, Hyun-Ook Yoon, Ji-Young Kim, Eun-Jung |
AuthorAffiliation | 2 Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Republic of Korea 1 Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute, Yangsan, Republic of Korea 3 Department of Anesthesia and Pain Medicine, Pusan National University Hospital, Busan, Republic of Korea 4 Department of Oral Physiology, School of Dentistry, Pusan National University, Yangsan, Republic of Korea |
AuthorAffiliation_xml | – name: 3 Department of Anesthesia and Pain Medicine, Pusan National University Hospital, Busan, Republic of Korea – name: 4 Department of Oral Physiology, School of Dentistry, Pusan National University, Yangsan, Republic of Korea – name: 2 Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Republic of Korea – name: 1 Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute, Yangsan, Republic of Korea |
Author_xml | – sequence: 1 givenname: Hyun-Ook orcidid: 0000-0002-1631-6910 surname: Jeon fullname: Jeon, Hyun-Ook organization: Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute, Yangsan, Republic of Korea – sequence: 2 givenname: In-Seok orcidid: 0000-0002-4429-3154 surname: Choi fullname: Choi, In-Seok organization: Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute, Yangsan, Republic of Korea – sequence: 3 givenname: Ji-Young orcidid: 0000-0002-9097-0531 surname: Yoon fullname: Yoon, Ji-Young organization: Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute, Yangsan, Republic of Korea – sequence: 4 givenname: Eun-Jung orcidid: 0000-0003-4982-9517 surname: Kim fullname: Kim, Eun-Jung organization: Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute, Yangsan, Republic of Korea – sequence: 5 givenname: Ji-Uk orcidid: 0000-0002-3971-2502 surname: Yoon fullname: Yoon, Ji-Uk organization: Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Republic of Korea – sequence: 6 givenname: Ah-Reum orcidid: 0000-0002-7108-1384 surname: Cho fullname: Cho, Ah-Reum organization: Department of Anesthesia and Pain Medicine, Pusan National University Hospital, Busan, Republic of Korea – sequence: 7 givenname: Hyung-Joon orcidid: 0000-0002-2962-9553 surname: Kim fullname: Kim, Hyung-Joon organization: Department of Oral Physiology, School of Dentistry, Pusan National University, Yangsan, Republic of Korea – sequence: 8 givenname: Cheul-Hong orcidid: 0000-0003-1536-9460 surname: Kim fullname: Kim, Cheul-Hong organization: Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute, Yangsan, Republic of Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29556554$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002316646$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kU1LJDEQhoMofs4f2MPSx91Dj_nodCeXBZEZFQRB9Bwy6cputDuZTXoE__2mexxxPQgFFcjzvm9RdYL2ffCA0DeC56ShFT9_avW6n1NMxHysudxDx5QJVkpGmv33N5ZHaJbSE8Y46xim-BAdUcl5zXl1jJYLa8EMRbBFhN5Z8IP2riuCL9YRypAGCKbTaSgMdF3RuozHDDk9uMw4X7y4IYYzdGB1l2D21k_R43LxcHld3t5d3Vxe3JaGCiLLupJE0LaV1taWCV6ZlebcVJZhkHUlKgF0RYEwbmrR5IEBV4JoDLVtm5Vh7BT93Pr6aNWzcSpoN_XfQT1HdXH_cKNoQwgVOLO_tux6s-qhNXnqqDu1jq7X8XVS_v_j3Z_s86K44AKTMezHm0EMfzeQBtW7NK5BewibpPLuuWC1JE1Gv3_Meg_ZLToDYguYGFKKYJVxw7TDHO06RbCazqqms47WQo2lZJbST9Kd-xeif7empus |
CitedBy_id | crossref_primary_10_1210_endrev_bnae023 crossref_primary_10_1016_j_fitote_2024_105831 crossref_primary_10_3389_fphar_2022_964771 |
Cites_doi | 10.1016/j.intimp.2009.03.001 10.1097/00000539-199910001-00003 10.2165/00003495-200565130-00007 10.1002/jcb.240550311 10.1016/S1534-5807(02)00369-6 10.1074/jbc.R109.041087 10.1359/jbmr.2001.16.9.1575 10.1016/S0092-8674(00)81569-X 10.1016/j.febslet.2007.03.033 10.17245/jdapm.2016.16.4.263 10.1046/j.1365-2613.2000.00164.x 10.1073/pnas.95.23.13835 10.3892/ijmm.2013.1406 10.7150/ijms.11839 10.1196/annals.1365.035 10.3109/s10165-008-0051-2 10.1038/nrg1122 10.1007/s00109-004-0612-6 10.1126/science.7939685 10.1359/jbmr.070401 10.1016/j.clinbiochem.2012.03.021 10.1359/jbmr.2002.17.7.1211 10.1084/jem.20051123 10.1002/1096-9896(2000)9999:9999<::AID-PATH645>3.0.CO;2-Q 10.1126/science.289.5484.1504 10.1146/annurev.immunol.15.1.707 |
ContentType | Journal Article |
Copyright | Copyright © 2018 Journal of Dental Anesthesia and Pain Medicine 2018 Journal of Dental Anesthesia and Pain Medicine |
Copyright_xml | – notice: Copyright © 2018 Journal of Dental Anesthesia and Pain Medicine 2018 Journal of Dental Anesthesia and Pain Medicine |
DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.17245/jdapm.2018.18.1.9 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2383-9317 |
EndPage | 17 |
ExternalDocumentID | oai_kci_go_kr_ARTI_2711280 PMC5858013 29556554 10_17245_jdapm_2018_18_1_9 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; |
GroupedDBID | AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS CITATION EBS EJD HYE M~E OK1 RPM .UV NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c2819-649182dd9ff6f3854cba55c4f30e964848e2b2e135c687017e0481a0e6fd7bc33 |
ISSN | 2383-9309 |
IngestDate | Tue Nov 21 21:39:55 EST 2023 Thu Aug 21 13:45:01 EDT 2025 Fri Jul 11 00:02:45 EDT 2025 Thu Jan 02 22:24:33 EST 2025 Tue Jul 01 00:39:19 EDT 2025 Thu Apr 24 23:03:47 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Cell Migration Cell Fusion Osteoclasts Remifentanil |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2819-649182dd9ff6f3854cba55c4f30e964848e2b2e135c687017e0481a0e6fd7bc33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 https://doi.org/10.17245/jdapm.2018.18.1.9 |
ORCID | 0000-0003-1536-9460 0000-0002-7108-1384 0000-0002-4429-3154 0000-0002-3971-2502 0000-0002-2962-9553 0000-0002-9097-0531 0000-0002-1631-6910 0000-0003-4982-9517 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5858013 |
PMID | 29556554 |
PQID | 2015836917 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_2711280 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5858013 proquest_miscellaneous_2015836917 pubmed_primary_29556554 crossref_citationtrail_10_17245_jdapm_2018_18_1_9 crossref_primary_10_17245_jdapm_2018_18_1_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20180201 |
PublicationDateYYYYMMDD | 2018-02-01 |
PublicationDate_xml | – month: 2 year: 2018 text: 20180201 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of dental anesthesia and pain medicine: JDAPM |
PublicationTitleAlternate | J Dent Anesth Pain Med |
PublicationYear | 2018 |
Publisher | The Korean Dental Society of Anesthsiology 대한치과마취과학회 |
Publisher_xml | – name: The Korean Dental Society of Anesthsiology – name: 대한치과마취과학회 |
References | Teitelbaum (10.17245/jdapm.2018.18.1.9_ref9) 2003; 4 Takayanagi (10.17245/jdapm.2018.18.1.9_ref18) 2002; 3 Vignery (10.17245/jdapm.2018.18.1.9_ref11) 2000; 81 Baik (10.17245/jdapm.2018.18.1.9_ref15) 2015; 12 Roodman (10.17245/jdapm.2018.18.1.9_ref6) 1996; 17 Yoon (10.17245/jdapm.2018.18.1.9_ref14) 2016; 16 Rao (10.17245/jdapm.2018.18.1.9_ref17) 1997; 15 Yagi (10.17245/jdapm.2018.18.1.9_ref20) 2007; 22 Teitelbaum (10.17245/jdapm.2018.18.1.9_ref5) 2000; 289 Felix (10.17245/jdapm.2018.18.1.9_ref21) 1994; 55 Hauge (10.17245/jdapm.2018.18.1.9_ref2) 2001; 16 Grigoriadis (10.17245/jdapm.2018.18.1.9_ref22) 1994; 266 Ishii (10.17245/jdapm.2018.18.1.9_ref24) 2008; 18 Takayanagi (10.17245/jdapm.2018.18.1.9_ref19) 2005; 83 Hadjidakis (10.17245/jdapm.2018.18.1.9_ref4) 2006; 1092 Raggatt (10.17245/jdapm.2018.18.1.9_ref3) 2010; 285 Ha (10.17245/jdapm.2018.18.1.9_ref16) 2009; 9 Kular (10.17245/jdapm.2018.18.1.9_ref23) 2012; 45 Zou (10.17245/jdapm.2018.18.1.9_ref27) 2002; 17 Corral (10.17245/jdapm.2018.18.1.9_ref25) 1998; 95 Lacey (10.17245/jdapm.2018.18.1.9_ref7) 1998; 93 Glass (10.17245/jdapm.2018.18.1.9_ref12) 1999; 89 Chen (10.17245/jdapm.2018.18.1.9_ref8) 2007; 581 Vignery (10.17245/jdapm.2018.18.1.9_ref10) 2005; 202 Scott (10.17245/jdapm.2018.18.1.9_ref13) 2005; 65 Hou (10.17245/jdapm.2018.18.1.9_ref26) 2013; 32 Chambers (10.17245/jdapm.2018.18.1.9_ref1) 2000; 192 |
References_xml | – volume: 9 start-page: 774 year: 2009 ident: 10.17245/jdapm.2018.18.1.9_ref16 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2009.03.001 – volume: 89 start-page: S7 year: 1999 ident: 10.17245/jdapm.2018.18.1.9_ref12 publication-title: Anesth Analg doi: 10.1097/00000539-199910001-00003 – volume: 65 start-page: 1793 year: 2005 ident: 10.17245/jdapm.2018.18.1.9_ref13 publication-title: Drugs doi: 10.2165/00003495-200565130-00007 – volume: 55 start-page: 340 year: 1994 ident: 10.17245/jdapm.2018.18.1.9_ref21 publication-title: J Cell Biochem doi: 10.1002/jcb.240550311 – volume: 3 start-page: 889 year: 2002 ident: 10.17245/jdapm.2018.18.1.9_ref18 publication-title: Dev Cell doi: 10.1016/S1534-5807(02)00369-6 – volume: 285 start-page: 25103 year: 2010 ident: 10.17245/jdapm.2018.18.1.9_ref3 publication-title: J Biol Chem doi: 10.1074/jbc.R109.041087 – volume: 16 start-page: 1575 year: 2001 ident: 10.17245/jdapm.2018.18.1.9_ref2 publication-title: J Bone Miner Res doi: 10.1359/jbmr.2001.16.9.1575 – volume: 93 start-page: 165 year: 1998 ident: 10.17245/jdapm.2018.18.1.9_ref7 publication-title: Cell doi: 10.1016/S0092-8674(00)81569-X – volume: 581 start-page: 2181 year: 2007 ident: 10.17245/jdapm.2018.18.1.9_ref8 publication-title: FEBS Lett doi: 10.1016/j.febslet.2007.03.033 – volume: 16 start-page: 263 year: 2016 ident: 10.17245/jdapm.2018.18.1.9_ref14 publication-title: J Dent Anesth Pain Med doi: 10.17245/jdapm.2016.16.4.263 – volume: 81 start-page: 291 year: 2000 ident: 10.17245/jdapm.2018.18.1.9_ref11 publication-title: Int J Exp Pathol doi: 10.1046/j.1365-2613.2000.00164.x – volume: 95 start-page: 13835 year: 1998 ident: 10.17245/jdapm.2018.18.1.9_ref25 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.23.13835 – volume: 17 start-page: 308 year: 1996 ident: 10.17245/jdapm.2018.18.1.9_ref6 publication-title: Endocr Rev – volume: 32 start-page: 503 year: 2013 ident: 10.17245/jdapm.2018.18.1.9_ref26 publication-title: Int J Mol Med doi: 10.3892/ijmm.2013.1406 – volume: 12 start-page: 583 year: 2015 ident: 10.17245/jdapm.2018.18.1.9_ref15 publication-title: Int J Med Sci doi: 10.7150/ijms.11839 – volume: 1092 start-page: 385 year: 2006 ident: 10.17245/jdapm.2018.18.1.9_ref4 publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1365.035 – volume: 18 start-page: 220 year: 2008 ident: 10.17245/jdapm.2018.18.1.9_ref24 publication-title: Mod Rheumatol doi: 10.3109/s10165-008-0051-2 – volume: 4 start-page: 638 year: 2003 ident: 10.17245/jdapm.2018.18.1.9_ref9 publication-title: Nat Rev Genet doi: 10.1038/nrg1122 – volume: 83 start-page: 170 year: 2005 ident: 10.17245/jdapm.2018.18.1.9_ref19 publication-title: J Mol Med (Berl) doi: 10.1007/s00109-004-0612-6 – volume: 266 start-page: 443 year: 1994 ident: 10.17245/jdapm.2018.18.1.9_ref22 publication-title: Science doi: 10.1126/science.7939685 – volume: 22 start-page: 992 year: 2007 ident: 10.17245/jdapm.2018.18.1.9_ref20 publication-title: J Bone Miner Res doi: 10.1359/jbmr.070401 – volume: 45 start-page: 863 year: 2012 ident: 10.17245/jdapm.2018.18.1.9_ref23 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2012.03.021 – volume: 17 start-page: 1211 year: 2002 ident: 10.17245/jdapm.2018.18.1.9_ref27 publication-title: J Bone Miner Res doi: 10.1359/jbmr.2002.17.7.1211 – volume: 202 start-page: 337 year: 2005 ident: 10.17245/jdapm.2018.18.1.9_ref10 publication-title: J Exp Med doi: 10.1084/jem.20051123 – volume: 192 start-page: 4 year: 2000 ident: 10.17245/jdapm.2018.18.1.9_ref1 publication-title: J Pathol doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH645>3.0.CO;2-Q – volume: 289 start-page: 1504 year: 2000 ident: 10.17245/jdapm.2018.18.1.9_ref5 publication-title: Science doi: 10.1126/science.289.5484.1504 – volume: 15 start-page: 707 year: 1997 ident: 10.17245/jdapm.2018.18.1.9_ref17 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.15.1.707 |
SSID | ssj0001723020 |
Score | 2.018045 |
Snippet | The structure and function of bone tissue is maintained through a constant remodeling process, which is maintained by the balance between osteoblasts and... Background: The structure and function of bone tissue is maintained through a constant remodeling process, which is maintained by the balance between... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 9 |
SubjectTerms | Original 치의학 |
Title | Effect of remifentanil on pre-osteoclast cell differentiation in vitro |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29556554 https://www.proquest.com/docview/2015836917 https://pubmed.ncbi.nlm.nih.gov/PMC5858013 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002316646 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Dental Anesthesia and Pain Medicine, 2018, 18(1), , pp.9-17 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe68cILAvFVvhQQb1VKEydx8jh1TCVoMIlNGk9W4tgsbE2qNEWCB_41_jXu7CRN24FgUpRWrp24d7-c7853F0JeJ2Dh-CxT8Ig7me15ibKTkGGURRB4KqN-kuhqnx-C2ZkXn_vng8GvXtTSqk7H4se1eSU34Sq0AV8xS_Y_ONtdFBrgO_AXzsBhOP8Tj5vSw6DvVXKeKwwDL_Ir9P9jcAemb5QCtON6hO757l0oteEGejq-5XVV_kE_zUyiZAKyEJTEpUneGi0SGNZuyKM7IT48OOm8N7E0m_iz76vC_lh2WUDTizI30sj-JNfNn0vTPc5tLXXWAQFzk4RT2HHb3HgmnLANZm6whDh_X1a4oXBoZtwGoqKOrSe_zNd7B1rmgQJB7YhOjBSV_TaT4rkrtDtwGgkc9ZZyM2RnkWCuhwU1vmbJAmsROOEYj3HU7wwEXMw1bNzIB6XXVLreKs19cjwFawvWeLpHbrmM6TiB4589Jx8DC0-XBu3-WJO4hXN4szMDLE3d3G5DT9orKnWdCbQdydtTjU7vkjsNZqwDA9B7ZCCL--TIgNMqldUHp1UW1iY4LQSntQVOKy8sDc4H5Ozo7el0Zjcv7bAF7snagReByZplkVKBoqHviTTxfeEpOpFR4IVeKN3UlQ71RQBrhcMkVixKJjJQGUsFpQ_JflEW8jGxXEzrliqVFKx-4TOsTegIqqRiMFClQ-K0JOKiqWiPL1a54mjZIoW5pjBHCnM8eDQko27MwtRz-WvvV0B5filyjmXY8fNLyS8rDsbmO-4yMFbCyZC8bBnDQTYj0eDRLFdLvJIf0iBy2JA8MozqbtryeUjYBgu7DnjDzV-K_ELXf28w9-TGI5-S2-vn9RnZr6uVfA66dZ2-0Pj9DfCR0S4 |
linkProvider | ISSN International Centre |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+remifentanil+on+pre-osteoclast+cell+differentiation+in+vitro&rft.jtitle=Journal+of+dental+anesthesia+and+pain+medicine%3A+JDAPM&rft.au=Jeon%2C+Hyun-Ook&rft.au=Choi%2C+In-Seok&rft.au=Yoon%2C+Ji-Young&rft.au=Kim%2C+Eun-Jung&rft.date=2018-02-01&rft.pub=The+Korean+Dental+Society+of+Anesthsiology&rft.issn=2383-9309&rft.eissn=2383-9317&rft.volume=18&rft.issue=1&rft.spage=9&rft.epage=17&rft_id=info:doi/10.17245%2Fjdapm.2018.18.1.9&rft_id=info%3Apmid%2F29556554&rft.externalDocID=PMC5858013 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2383-9309&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2383-9309&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2383-9309&client=summon |